- ►ivvitaminsnj.us [PDF] SJ Padayatty, H Sun, Y Wang, HD Riordan, SM … - Annals of internal medicine, 2004 - Am Coll Physicians From the National Institute of Diabetes and Digestive and Kidney Diseases, the
National Cancer Institute, and the Clinical Center, National Institutes of
Health, Bethesda, Maryland; the Food and Drug Administration, Rockville, ... Cited by 106 - Related articles - BL Direct - All 21 versions
- ►nih.gov Q Chen, MG Espey, MC Krishna, JB Mitchell, … - Proceedings of the National Academy of Sciences of …, 2005 - National Acad Sciences Human pharmacokinetics data indicate that iv ascorbic acid (ascorbate) in
pharmacologic concentrations could have an unanticipated role in cancer
treatment. Our goals here were to test whether ascorbate killed cancer ... Cited by 112 - Related articles - BL Direct - All 40 versions
- ►ecmaj.ca SJ Padayatty, HD Riordan, SM Hewitt, A Katz, … - Canadian Medical Association Journal, 2006 - Can Med Assoc Early clinical studies showed that high-dose vitamin C, given by intravenous and
oral routes, may improve symptoms and prolong life in patients with terminal
cancer. Double-blind placebo-controlled studies of oral vitamin C therapy ... Cited by 35 - Related articles - BL Direct - All 41 versions
JJ Casciari, NH Riordan, TL Schmidt, XL … - British journal of cancer, 2001 - bcrionline.org Vitamin C (ascorbic acid, ascorbate) is a major water soluble antioxidant with a
variety of biological functions. It plays roles in collagen and carnitine
synthesis and may be important in main- taining proper immune cell function ... Cited by 45 - Related articles - BL Direct - All 5 versions
- ►ivvitaminsnj.us [PDF] MJ González, JR Miranda-Massari, EM Mora, … - Integr Cancer Ther, 2005 - ict.sagepub.com The effect of ascorbic acid on cancer has been a subject of great controversy.
This is a follow-up review of the 1979 arti- cle by Cameron, Pauling, and
Leibovitz published in Cancer Research. In this updated version, the ... Cited by 30 - Related articles - All 11 versions
CG Moertel, TR Fleming, ET Creagan, J … - New England Journal of Medicine, 1985 - content.nejm.org It has been claimed that high-dose vitamin C is beneficial in the treatment of
patients with advanced cancer, especially patients who have had no prior
chemotherapy. In a double-blind study 100 patients with advanced colorectal ... Cited by 206 - Related articles - All 6 versions
- ►nih.gov Q Chen, MG Espey, AY Sun, JH Lee, MC … - Proceedings of the National Academy of Sciences, 2007 - National Acad Sciences Ascorbate (ascorbic acid, vitamin C), in pharmacologic concentrations easily
achieved in humans by iv administration, selectively kills some cancer cells but
not normal cells. We proposed that pharmacologic ascorbate is a prodrug for ... Cited by 37 - Related articles - BL Direct - All 12 versions
- ►nih.gov Q Chen, MG Espey, AY Sun, C Pooput, KL Kirk … - Proceedings of the National Academy of Sciences, 2008 - National Acad Sciences Ascorbic acid is an essential nutrient commonly regarded as an antioxidant. In
this study, we showed that ascorbate at pharmacologic concentrations was a
prooxidant, generating hydrogen-peroxide-dependent cytotoxicity toward a ... Cited by 34 - Related articles - All 10 versions
SJ Padayatty, M Levine - Journal of the American College of Nutrition, 2000 - Am Coll Nutrition Lack of vitamin C results in scurvy. Daily intake of 100 milligrams of vitamin C
will prevent scurvy for one month if further ingestion ceases. However, optimum
requirements of vitamin C for good health are unknown. This has led to wild ... Cited by 23 - Related articles - BL Direct - All 5 versions
P Studies, H Persons - Ann Intern Med, 2004 - bcrionline.org ~ebastian 1. Padayatty, MRCP, PhD; He Sun, PhD, CBS; Yaohui Wang, MD; Hugh D.
Riordan, MD; Stephen M. Hewitt, MD, PhD; Arie Katz, MD; Robert A. Wesley, PhD;
and Mark Levine, MD ... Background: Vitamin C at high concentrations is ... Related articles - View as HTML - All 2 versions
